one study that just finished
Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2 (COVID-19 PEP)
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 3000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Intervention Model Description: Asymptomatic participants are randomized and analyzed separate from symptomatic participants.
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Post-exposure Prophylaxis or Preemptive Therapy for SARS-Coronavirus-2: A Pragmatic Randomized Clinical Trial
Actual Study Start Date : March 17, 2020
Estimated Primary Completion Date : May 1, 2020
Estimated Study Completion Date : May 14, 2020
https://clinicaltrials.gov/ct2/show/NCT04308668?cond=Covid-19&cntry=US&draw=2&rank=5